There’s more to blue cheese than just the stench
Marbled veins of blue line the otherwise antique white surface.
As you approach, the pungent smell fills your nostrils, akin to gym socks for some.
But there’s far more to blue cheese than just the stink. The marbled veins of blue, which are edible Penicilliummolds, produce compounds with antifungal, antibacterial, and other biological properties in high doses also known as natural products.
![Sydney Johnson (at left) and Pablo Sobrado found a way to synthesize on a large scale a naturally occurring compound that hasn’t previously been used for antibacterial applications.](/getmedia/79ee2f49-0868-46b6-af87-e52fd49bf16a/Johnson-Sobrado-890x593.jpg)
Virginia Tech researchers found a new, efficient way to synthesize some of these beneficial blue cheese compounds in a way that avoids the use of harmful chemicals. Previously, the synthesization of these compounds was either extremely low in yield or required the use of harmful or dangerous chemicals.
“This discovery explains the mechanism behind a new reaction in our field, filling a knowledge gap,” said Sydney Johnson Ph.D. ’24, the lead author who earned her doctorate in biochemistry.
Antibacterial resistance has become a growing problem for society, which was caused by the overuse of natural products used on the market for decades, Johnson said.
By finding a way to synthesize on a large scale a naturally occurring compound that hasn’t previously been used for antibacterial applications, Virginia Tech researchers were able to evade the existing antibacterial resistances.
“We work with an enzyme that can help create a natural product that has a unique structure that would make it very difficult for pathogens to become resistant,” Johnson said. “Existing pathogens would have to evolve to be resistant to this new compound.”
The paper was recently published in ACS Biochemistry.
![This publication lays the foundation to utilize the enzyme to synthesize the natural products,” Sydney Johnson said.](/getmedia/71ead139-f9ed-4145-99f0-0557ae9dafda/Johnson-Sydney-480x320.jpg)
“I like to train innovative scientists that work on trying to move the science forward by developing projects that move the entire field forward,” said Pablo Sobrado, professor of biochemistry who leads the Sobrado Lab and is also a researcher on the paper. “Sydney achieved that with this research.”
Enzymes are proteins that help speed up chemical reactions. For their experiment, researchers used an enzyme that produces something called roquefortine L. Parts of its chemical structure are biologically active, which means that it can have beneficial properties such as antimicrobial activities.
In addition, the production of roquefortine L is central to the production of other molecules called glandiclone, melegranin, and oxaline, which have been shown to have broad antimicrobial properties and promising anticancer effects against human breast and leukemia cancer cells.
This enzyme attaches two hydroxyl groups to a nitrogen atom, which are functional groups found in sugars and alcohols. A hydroxyl group consists of one hydrogen and one oxygen atom. Through a complex chemical process, the hydroxyl groups then develop an entirely different functionality.
“This has not been studied in detail before, and Sydney showed how the enzyme holds on first to the product that has the one hydroxyl group, attaches the second group, and then obtains the final product,” Sobrado said.
Many fungal species make this compound naturally, and it’s relatively new in the biochemistry field to research how to synthesize these processes at a large scale. According to the researchers, the reaction mechanism and the actual chemistry that takes place on the involved nitrogen atom is completely novel from other publications.
“This publication lays the foundation to utilize the enzyme to synthesize the natural products,” Johnson said. “The improvements make this process much more marketable. Eventually, we could get a drug containing one of these compounds or something similar to it to the market.”
This article is republished from the Virginia Tech News page. Read the original here.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
![From the JBC archives: Madness, indoles and mercury-based cathartics](/getattachment/e26ef62e-685d-450f-b5e4-113430cfb888/JBC-archives-02-11-25-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
From the JBC archives: Madness, indoles and mercury-based cathartics
A 1907 paper sought to resolve an ongoing question of whether indole, a bacterial molecule in the gut, could cause insanity if overproduced.
![From the journals: JBC](/getattachment/05f125e8-aa95-4a9e-bd9c-896b3f72923c/FTJ-JBC-02-07-25-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
From the journals: JBC
Linking modified cysteines to cell migration. Recognizing protein tags for degradation. Disrupting C. difficile toxin production. Read about recent JBC papers on these topics.
![Becoming a scientific honey bee](/getattachment/7cb3cada-2249-4121-a9f5-63aa5bd6f213/Becoming-scientific-honey-bee-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
Becoming a scientific honey bee
At the World Science Forum, a speaker’s call for scientists to go out and “make honey” felt like the answer to a question Katy Brewer had been considering for a long time.
![Mutant RNA exosome protein linked to neurodevelopmental defects](/getattachment/dbfd7c8c-5104-4903-8e97-2c82f9d97262/Mutant-RNA-exosome-protein-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
Mutant RNA exosome protein linked to neurodevelopmental defects
Researchers at Emory University find that a missense mutation impairs RNA exosome assembly and translation and causes neurological disease.
![Study sheds light on treatment for rare genetic disorder](/getattachment/0f757086-65aa-452a-a87e-e2f381aee087/Treatment-for-rare-genitic-disorder-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
Study sheds light on treatment for rare genetic disorder
Aaron Hoskins’ lab partnered with a drug company to understand how RNA-targeting drugs work on spinal muscular atrophy, a disorder resulting from errors in production of a protein related to muscle movement.
![Examining mechanisms of protein complex at a basic cell biological level](/getattachment/f09ff397-048a-494d-9eea-d4b5eae8938d/Munson-480x270.jpg?lang=en-US&width=480&height=270&ext=.jpg)
Examining mechanisms of protein complex at a basic cell biological level
Mary Munson is co-corresponding author on a study revealing functions and mechanisms of the exocyst that are essential to how molecules move across a membrane through vesicles in a cell.